The escalating global Mpox outbreak has been met with a concerning revelation. Two distinct studies have indicated that the ...

Amid the rising global outbreak of Mpox, two separate studies have shown that the efficacy of Bavarian Nordic’s vaccine ...

Two separate studies have shown that the efficacy of Bavarian Nordic’s vaccine against the deadly infectious disease wanes ...

One dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine is moderately effective against mpox infection in at-risk communities.

Two recent studies reveal that the efficacy of Bavarian Nordic's Mpox vaccine significantly declines within 6-12 months ...

With more than 200 mpox-related deaths reported globally, the EMA has approved Imvanex for adolescents aged 12-17 years.

In an emulated target trial, a single dose of modified vaccinia Ankara-Bavarian Nordic vaccine was moderately effective in ...

As of now, when it comes to protection against prevalent diseases, Dr Gagandeep Kang, a renowned virologist, points that our ...

Jolaoso described the unfounded claim of vaccines “being unsafe or a tool designed to reduce African populations” as lacking ...

Gavi (the Global Alliance for Vaccines and Immunization) has entered an advance purchase agreement with Bavarian Nordic to ...

The rate of mpox infection in the vaccinated group was 0.09 for every 1,000 person-days as compared to 0.20 in the ...